(Q44790291)

English

Persistent transgene expression following intravenous administration of a liposomal complex: role of interleukin-10-mediated immune suppression

scientific article published in March 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Persistent transgene expression following intravenous administration of a liposomal complex: role of interleukin-10-mediated immune suppression (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Ara A Vaporciyan

6

object named as

Ara Vaporciyan

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Isao Ito

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Tomoyuki Saeki

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Imran Mohuiddin

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Yuji Saito

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Cynthia D Branch

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Jack A Roth

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Rajagopal Ramesh

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

318-327

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Liposomal gene delivery: A complex package

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

DNA sequences in cationic lipid:pDNA-mediated systemic toxicities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Decreased macrophage-mediated cytotoxicity in mammary-tumor-bearing mice is related to alteration of nitric-oxide production and/or release.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Modulation of the immune system by mammary tumor-derived factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

The biology of cachectin/TNF--a primary mediator of the host response

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

The pathophysiology of tumor necrosis factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Macrophage deactivation by interleukin 10

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Biological properties of interleukin 10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Improved DNA: liposome complexes for increased systemic delivery and gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Adoptive transfer of acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Adaptation of the dichlorofluorescein assay for detection of radiation-induced oxidative stress in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Analysis of air pollution particulate-mediated oxidant stress in alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

The respiratory burst activity of activated eosinophils in atopic asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.01.007

7 January 2021

Identifiers

10.1016/J.YMTHE.2004.01.007

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44790291&oldid=2042049212"